#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rosai-Dorfman syndrome Arteriovenous malformation Immune thrombocytopenia Hypophosphatasia Pyruvate kinase deficiency anaemia Emphysema Richter's syndrome Small cell lung cancer recurrent Neuropathic arthropathy Indolent systemic mastocytosis Medullary thyroid cancer Chronic myeloid leukaemia Endometrial cancer recurrent Adrenocortical carcinoma Skin cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Life with Disease Myxofibrosarcoma – Trials in Disease Rhabdomyosarcoma – Basic Information Piriformis syndrome Glycogen storage disease type II – Trials in Disease Activated PI3 kinase delta syndrome – Diagnostics Bronchiolitis obliterans syndrome – Diagnostics Short-bowel syndrome – Basic Information Alagille syndrome Hereditary angioedema – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acp-204 Tartrate L-Lysine Hydrochloride Brexpiprazole Fumarate Zanubrutinib Bms-986435 Elraglusib Calcium Polystyrene Sulfonate Bexotegrast Tng462 Dexrazoxane Hydrochloride Arginine Hydrochloride Arginine Brexpiprazole Dabrafenib Mesylate Teclistamab Buspirone Hydrochloride Anselamimab Afamelanotide Brepocitinib Tosilate Tominersen More therapies…

    Learn about Your Condition

    Cardiac failure congestive Subarachnoid haemorrhage Chronic myeloid leukaemia Macular oedema Kearns-Sayre syndrome Cholangitis sclerosing Mitral valve prolapse Anal fistula Multiple sclerosis Anal cancer stage III Cirrhosis alcoholic Alport's syndrome Thrombotic microangiopathy Atopic keratoconjunctivitis Hairy cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Clonazepam for Treating Burning Mouth Syndrome in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Burning mouth syndrome
    Investigated Drugs:
    • Clonazepam
    Sweden

  • Study on the Effectiveness of Vaginal Micronized Progesterone for Infertility in Patients Undergoing Assisted Conception with Frozen Embryo Transfer (AC-FET)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Progesterone, Micronised
    • Estradiol Hemihydrate
    • Progesterone
    Spain

  • Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Methotrexate
    Austria Italy The Netherlands Norway Romania Sweden

  • Study of NVL-520 for Patients with Advanced ROS1-Positive Lung Cancer and Other Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zidesamtinib
    Belgium France Germany Italy The Netherlands Spain

  • Study on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older

    Recruiting

    4 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • Diacerein
    Austria Belgium France Greece Ireland Italy +2

  • Study on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Mitomycin
    • Docetaxel
    Spain
Previous Page
1 … 472 473 474 475 476 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!